CN Stock MarketDetailed Quotes

Sichuan Kelun Pharmaceutical (002422)

Watchlist
  • 40.03
  • -0.49-1.21%
15min DelayPost Market Sep 17 14:58 CST
63.68BMarket Cap34.81P/E (TTM)

Sichuan Kelun Pharmaceutical (002422) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: CNY
2026/H1
2026/Q1
2025/FY
2025/Q9
2025/H1
2025/Q1
2024/FY
2024/Q9
2024/H1
2024/Q1
2023/FY
2023/Q9
2023/H1
2023/Q1
2022/FY
2022/Q9
2022/H1
2022/Q1
2021/FY
2021/Q9
Total Operating Revenue
-2.70%8.84B
-2.98%4.26B
-15.13%18.51B
-20.92%13.28B
-23.20%9.08B
-29.42%4.39B
+1.67%21.81B
+6.64%16.79B
+9.52%11.83B
+10.32%6.22B
+12.69%21.45B
+12.93%15.74B
+18.35%10.80B
+25.79%5.64B
+10.19%19.04B
+9.88%13.94B
+10.84%9.12B
+7.97%4.48B
+4.94%17.28B
+8.77%12.69B
Operating Revenue
-2.70%8.84B
-2.98%4.26B
-15.13%18.51B
-20.92%13.28B
-23.20%9.08B
-29.42%4.39B
+1.67%21.81B
+6.64%16.79B
+9.52%11.83B
+10.32%6.22B
+12.69%21.45B
+12.93%15.74B
+18.35%10.80B
+25.79%5.64B
+10.19%19.04B
+9.88%13.94B
+10.84%9.12B
+7.97%4.48B
+4.94%17.28B
+8.77%12.69B
Other Operating Revenues
+3.35%312.70M
----
-8.10%648.53M
----
-16.87%302.55M
----
-4.59%705.65M
----
-0.83%363.93M
----
+69.01%739.64M
----
+82.92%366.98M
----
+28.25%437.62M
----
+17.72%200.62M
----
+1.38%341.23M
----
Total Operating Cost
+3.87%8.12B
+7.03%3.99B
-7.93%16.44B
-11.56%11.86B
-15.34%7.82B
-21.81%3.73B
-2.33%17.85B
-0.41%13.41B
+0.92%9.24B
+2.42%4.77B
+6.12%18.28B
+8.85%13.47B
+11.36%9.15B
+9.94%4.65B
+5.73%17.22B
+3.30%12.37B
+5.17%8.22B
+4.86%4.23B
+3.46%16.29B
+7.07%11.98B
Cost of Sales
+1.54%4.63B
+3.37%2.33B
-8.37%9.66B
-13.22%6.92B
-16.42%4.56B
-17.96%2.25B
+3.25%10.54B
+7.61%7.97B
+7.95%5.46B
+7.68%2.75B
+12.89%10.21B
+15.99%7.41B
+20.96%5.06B
+21.52%2.55B
+18.02%9.04B
+13.99%6.39B
+15.70%4.18B
+12.05%2.10B
+1.69%7.66B
+8.42%5.60B
Operating Tax Surcharges
+9.56%133.09M
+32.61%70.65M
-6.65%257.85M
-10.46%187.05M
-11.40%121.49M
-16.45%53.28M
-8.75%276.22M
-10.25%208.89M
-11.17%137.12M
+0.25%63.76M
+20.51%302.73M
+27.62%232.75M
+39.70%154.35M
+18.08%63.60M
+12.23%251.20M
+12.68%182.37M
+7.82%110.48M
+11.59%53.86M
+12.61%223.82M
+12.00%161.84M
Operating Expense
+8.05%1.55B
+14.45%722.55M
-12.98%3.04B
-17.80%2.15B
-25.09%1.44B
-42.70%631.31M
-21.51%3.49B
-19.54%2.61B
-12.83%1.92B
-5.84%1.10B
-5.89%4.45B
-4.02%3.25B
-2.32%2.20B
-2.97%1.17B
-5.86%4.73B
-10.13%3.39B
-9.53%2.25B
-3.91%1.21B
+2.86%5.02B
+2.58%3.77B
Administrative Expenses
-10.86%549.45M
-10.59%269.86M
-7.79%1.21B
-5.02%930.47M
+0.34%616.39M
-10.19%301.81M
+14.57%1.31B
+38.62%979.69M
+23.89%614.30M
+18.75%336.05M
+22.93%1.14B
-18.31%706.77M
-17.14%495.86M
-14.45%283.00M
-18.64%929.03M
-1.65%865.19M
+1.56%598.46M
+3.27%330.78M
+12.90%1.14B
+19.41%879.74M
Research and Development
+15.69%1.21B
+21.07%586.14M
+1.60%2.21B
+3.06%1.63B
-2.78%1.05B
-3.72%484.12M
+11.68%2.17B
-4.89%1.58B
+0.21%1.08B
+2.27%502.82M
+8.27%1.94B
+38.30%1.67B
+28.99%1.08B
+17.89%491.66M
+3.37%1.80B
+1.27%1.20B
+8.87%834.07M
-0.35%417.05M
+13.70%1.74B
+18.97%1.19B
Financial Expense
+24.86%39.58M
+183.70%11.71M
+8.04%71.50M
-14.87%46.40M
+15.92%31.70M
-75.48%4.13M
-71.69%66.18M
-73.51%54.50M
-83.52%27.34M
-82.43%16.83M
-51.28%233.76M
-41.05%205.77M
-30.80%165.87M
-24.75%95.81M
-5.10%479.83M
-7.66%349.09M
-4.67%239.70M
+4.16%127.32M
-14.64%505.65M
-19.09%378.05M
-Interest Financial Expense
-11.03%47.83M
-12.85%23.12M
-32.18%102.84M
-32.24%83.74M
-39.94%53.76M
-44.32%26.52M
-58.06%151.62M
-57.56%123.59M
-61.06%89.51M
-61.94%47.64M
-23.92%361.54M
-14.79%291.20M
-2.95%229.86M
+0.30%125.17M
-8.32%475.22M
-12.33%341.72M
-7.06%236.86M
-0.32%124.79M
-6.58%518.34M
-8.64%389.77M
-Interest Financial Income
-4.62%-23.93M
-6.36%-13.48M
-13.71%-81.42M
+9.60%-50.58M
+44.17%-22.87M
+43.20%-12.67M
+30.88%-71.60M
+26.29%-55.95M
+15.04%-40.96M
-33.29%-22.31M
-134.19%-103.59M
-122.55%-75.91M
-107.46%-48.22M
-115.35%-16.74M
-51.50%-44.23M
-59.71%-34.11M
-76.74%-23.24M
-24.42%-7.77M
+3.89%-29.20M
+25.29%-21.36M
Credit Impairment Loss
+13.99%-24.35M
-114.18%-13.73M
+78.47%-23.50M
+52.98%-36.11M
+59.38%-28.31M
+86.17%-6.41M
-137.32%-109.13M
+0.71%-76.79M
-88.14%-69.70M
-411.67%-46.37M
+26.41%-45.98M
-80.31%-77.34M
+12.40%-37.05M
-18.19%-9.06M
-40.54%-62.49M
-248.21%-42.89M
-327.32%-42.29M
+7.54%-7.67M
+13.37%-44.47M
+62.58%-12.32M
Asset Impairment Loss
+14.62%-57.10M
--0.00
+11.00%-116.22M
-119.29%-66.88M
-156.77%-66.88M
--0.00
-0.03%-130.59M
+34.55%-30.50M
+44.15%-26.05M
----
-195.95%-130.55M
-65.77%-46.60M
-88.97%-46.63M
-400.64%-14.76M
+12.52%-44.11M
+4.49%-28.11M
+16.15%-24.68M
--4.91M
+12.28%-50.43M
+6.00%-29.43M
Fair Value Change Income
+21.66%18.42M
-5.70%7.20M
+38.76%27.61M
+56.61%21.42M
+177.01%15.14M
+159.62%7.63M
+35.67%19.90M
+15787.77%13.68M
+67.43%5.47M
+99.02%2.94M
+48.73%14.67M
-102.71%-87.18K
+82.19%3.26M
-38.96%1.48M
+104.27%9.86M
+127.39%3.22M
+1433.00%1.79M
+519081.97%2.42M
+1046.32%4.83M
--1.42M
Investment income
-17.05%110.37M
+2.64%62.93M
-39.01%210.41M
-38.39%177.60M
-37.75%133.06M
-45.17%61.31M
-3.86%345.02M
+7.97%288.27M
+24.71%213.76M
+25.29%111.84M
+52.99%358.88M
+55.18%266.98M
+56.41%171.41M
+74.91%89.26M
+9.19%234.58M
+27.39%172.05M
+140.77%109.59M
+32.20%51.03M
+126.55%214.83M
+115.22%135.05M
-Investment Income Associates
-16.75%102.91M
+1.00%59.16M
-42.93%182.89M
-41.81%158.95M
-40.75%123.61M
-47.95%58.58M
-8.99%320.47M
+5.32%273.16M
+19.85%208.63M
-50.67%112.56M
+54.30%352.11M
+65.32%259.35M
+78.41%174.07M
+500.32%228.19M
+79.25%228.19M
+21.27%156.88M
+138.22%97.57M
+2.60%38.01M
+46.61%127.30M
+106.75%129.37M
Asset Deal Income
-80.18%1.29M
+93.26%1.15M
+558.82%5.32M
+552.96%5.74M
+373.13%6.49M
-7.51%597.48K
-69.26%807.54K
-53.87%879.45K
-16.23%1.37M
+156.42%646.02K
-51.34%2.63M
-51.70%1.91M
-60.80%1.64M
-128.15%-1.15M
+168.01%5.40M
+130.39%3.95M
+138.65%4.18M
+256.05%4.07M
+60.39%-7.94M
+2.72%-12.99M
Other Revenues
-30.47%131.47M
-56.60%29.83M
+0.44%340.28M
+10.49%265.90M
-3.26%189.08M
-38.54%68.72M
+21.89%338.78M
+34.12%240.64M
+39.59%195.46M
+41.66%111.82M
+17.19%277.94M
+3.26%179.43M
-0.76%140.02M
+156.41%78.93M
+9.76%237.18M
+21.67%173.77M
+32.81%141.09M
-14.03%30.78M
-33.46%216.09M
-31.61%142.82M
Operating Profit
-40.72%897.21M
-55.09%356.49M
-43.04%2.52B
-53.28%1.78B
-48.03%1.51B
-51.38%793.74M
+21.13%4.43B
+46.68%3.81B
+54.86%2.91B
+44.77%1.63B
+66.46%3.65B
+40.59%2.60B
+71.44%1.88B
+238.15%1.13B
+66.32%2.20B
+98.46%1.85B
+110.94%1.10B
+88.32%333.47M
+30.68%1.32B
+39.22%930.93M
Add:Non-operating Income
+28556.32%708.10M
+9362.61%101.29M
+818.43%80.91M
-24.70%4.64M
-19.09%2.47M
-36.79%1.07M
-25.69%8.81M
+36.48%6.16M
+42.54%3.05M
+196.74%1.69M
+59.93%11.86M
+93.00%4.52M
+66.06%2.14M
+54.58%570.68K
+123.45%7.41M
+17.29%2.34M
+1.15%1.29M
+31.44%369.17K
-73.67%3.32M
-61.49%1.99M
Less:Non-operating Expense
-46.95%52.12M
-22.60%16.74M
+32.29%198.13M
+22.75%135.62M
+96.80%98.26M
+131.35%21.62M
+75.02%149.77M
+96.59%110.48M
+87.39%49.93M
-25.88%9.35M
-36.44%85.57M
-43.52%56.20M
-22.83%26.64M
+28.42%12.61M
-7.49%134.64M
+226.13%99.51M
+97.78%34.52M
+75.91%9.82M
+115.52%145.54M
-43.73%30.51M
Gross Profit
+9.56%1.55B
-42.96%441.05M
-43.91%2.40B
-55.50%1.65B
-50.52%1.42B
-52.41%773.18M
+19.69%4.29B
+45.56%3.71B
+54.38%2.87B
+45.65%1.62B
+73.14%3.58B
+45.44%2.55B
+74.49%1.86B
+244.29%1.12B
+75.60%2.07B
+93.97%1.75B
+111.12%1.06B
+88.63%324.02M
+23.31%1.18B
+45.63%902.41M
Less:Income tax
-58.22%126.92M
-127.86%-31.65M
-42.97%526.62M
-48.49%404.16M
-53.21%303.79M
-66.49%113.60M
-1.11%923.40M
+94.82%784.66M
+134.70%649.29M
+118.01%338.99M
+156.75%933.79M
+37.88%402.77M
+52.63%276.65M
+193.29%155.50M
+17.51%363.70M
+86.87%292.10M
+212.64%181.26M
+208.20%53.02M
+89.23%309.50M
+71.56%156.32M
Net Profit
+28.05%1.43B
-28.33%472.70M
-44.16%1.88B
-57.39%1.24B
-49.73%1.11B
-48.70%659.59M
+27.03%3.36B
+36.30%2.92B
+40.31%2.22B
+33.93%1.29B
+55.30%2.65B
+46.96%2.14B
+78.98%1.58B
+254.27%960.07M
+96.31%1.70B
+95.45%1.46B
+97.92%882.31M
+75.32%271.00M
+9.68%868.12M
+41.17%746.09M
Net Profit from Continuing Operations
+28.05%1.43B
-28.33%472.70M
-44.16%1.88B
-57.39%1.24B
-49.73%1.11B
-48.70%659.59M
+27.03%3.36B
+36.30%2.92B
+40.31%2.22B
+33.93%1.29B
+55.30%2.65B
+46.96%2.14B
+78.98%1.58B
+254.27%960.07M
+96.31%1.70B
+95.45%1.46B
+97.92%882.31M
+75.32%271.00M
+9.68%868.12M
+41.17%746.09M
Net Income from Discontinuing Operating
----
----
----
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Less:Minority Profit
+163.62%298.49M
-74.78%19.00M
-58.86%175.28M
-90.20%44.10M
-72.76%113.23M
-70.98%75.34M
+123.62%426.06M
+150.46%450.08M
+136.92%415.67M
+78.28%259.61M
+17379.60%190.53M
+240.06%179.70M
+1132.50%175.44M
+814.69%145.62M
+99.53%-1.10M
+151.71%52.84M
+130.28%14.23M
+2.35%-20.38M
-518.42%-234.44M
-477.66%-102.20M
Net Profit of Parent Company Owners
+12.71%1.13B
-22.34%453.70M
-42.03%1.70B
-51.41%1.20B
-44.41%1.00B
-43.07%584.24M
+19.53%2.94B
+25.85%2.47B
+28.24%1.80B
+26.00%1.03B
+44.03%2.46B
+39.70%1.96B
+61.71%1.40B
+179.52%814.45M
+54.67%1.71B
+65.68%1.41B
+76.15%868.08M
+66.08%291.37M
+32.94%1.10B
+69.16%848.29M
Basic EPS
+12.70%0.71
-21.62%0.29
-42.47%1.07
-52.23%0.75
-45.22%0.63
-44.78%0.37
+10.06%1.86
+16.30%1.57
+18.56%1.15
+17.54%0.67
+38.52%1.69
+35.00%1.35
+56.45%0.97
+185.00%0.57
+56.41%1.22
+66.67%1.00
+77.14%0.62
+66.67%0.20
+34.48%0.78
+71.43%0.60
Diluted EPS
+12.70%0.71
-21.62%0.29
-42.47%1.07
-52.23%0.75
-45.22%0.63
-44.78%0.37
+16.98%1.86
+23.62%1.57
+26.37%1.15
+26.42%0.67
+38.26%1.59
+33.68%1.27
+51.67%0.91
+165.00%0.53
+47.44%1.15
+58.33%0.95
+71.43%0.60
+66.67%0.20
+34.48%0.78
+71.43%0.60
Other Composite Income
+0.71%-39.31M
-811.63%-57.11M
-564.40%-51.73M
-145.56%-43.27M
-295.03%-39.59M
-641.12%-6.26M
+118.31%11.14M
-124.00%-17.62M
-76.68%20.30M
-100.35%-845.21K
-125.22%-60.84M
-72.62%73.41M
-24.74%87.05M
+1312.52%241.24M
+406.74%241.24M
+930.49%268.13M
+424.95%115.67M
-785.87%-19.90M
+40.29%-78.65M
+21.45%-32.29M
Other Composite Income of Parent Company Owners
+9.42%-34.99M
-626.26%-56.72M
-448.85%-49.43M
-177.22%-38.59M
-291.73%-38.63M
-439.69%-7.81M
+123.47%14.17M
-119.67%-13.92M
-76.21%20.15M
-100.61%-1.45M
-125.51%-60.37M
-72.90%70.76M
-25.01%84.70M
+1321.41%236.68M
+419.93%236.68M
+914.57%261.15M
+421.12%112.95M
-906.88%-19.38M
+45.04%-73.98M
+30.20%-32.06M
Other Composite Income of Minority Owners
-350.28%-4.32M
-125.23%-389.81K
+24.26%-2.30M
-26.40%-4.68M
-734.75%-959.08K
+156.77%1.55M
-541.67%-3.03M
-239.56%-3.70M
-93.58%151.09K
-86.81%601.78K
-110.35%-472.44K
-62.03%2.65M
-13.45%2.35M
+980.31%4.56M
+197.77%4.56M
+3195.79%6.98M
+744.00%2.72M
-203.83%-518.41K
-261.39%-4.67M
-104.67%-225.45K
Total Composite Income
+29.11%1.39B
-36.39%415.60M
-45.88%1.83B
-58.62%1.20B
-51.96%1.07B
-49.16%653.32M
+30.45%3.37B
+30.99%2.90B
+34.20%2.24B
+6.96%1.28B
+32.91%2.59B
+28.39%2.22B
+66.96%1.67B
+378.41%1.20B
+146.43%1.95B
+141.86%1.73B
+143.29%997.98M
+59.46%251.10M
+19.66%789.47M
+46.45%713.81M
Total Composite Income of Parent Company Owners
+13.60%1.09B
-31.13%396.99M
-43.98%1.65B
-52.70%1.16B
-47.15%962.00M
-43.75%576.43M
+23.14%2.95B
+20.79%2.46B
+22.29%1.82B
-2.51%1.02B
+23.36%2.40B
+22.05%2.03B
+51.72%1.49B
+286.45%1.05B
+88.81%1.94B
+104.18%1.67B
+114.37%981.03M
+52.94%272.00M
+48.05%1.03B
+79.18%816.23M
Total Composite Income of Minority Owners
+162.02%294.18M
-75.80%18.61M
-59.11%172.98M
-91.17%39.43M
-73.00%112.27M
-70.45%76.89M
+122.58%423.03M
+144.79%446.38M
+133.87%415.82M
+73.27%260.22M
+5391.29%190.05M
+204.81%182.35M
+948.81%177.80M
+818.80%150.18M
+101.45%3.46M
+158.41%59.82M
+135.73%16.95M
-2.59%-20.89M
-582.83%-239.11M
-421.20%-102.42M
Deadline
Jun 30, 2026
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Accounting Standard
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
2026/H12026/Q12025/FY2025/Q92025/H12025/Q12024/FY2024/Q92024/H12024/Q12023/FY2023/Q92023/H12023/Q12022/FY2022/Q92022/H12022/Q12021/FY2021/Q9

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.